BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32654522)

  • 1. The common variant of rs6214 in insulin like growth factor 1 (
    Sabzikarian M; Mahmoudi T; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Nobakht H; Dabiri R; Mansour-Ghanaei F; Derakhshan F; Zali MR
    Arch Physiol Biochem; 2023 Feb; 129(1):10-15. PubMed ID: 32654522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.
    Nobakht H; Mahmoudi T; Rezamand G; Tabaeian SP; Jeddi G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Kaboli SA; Derakhshan F; Zali MR
    Lab Med; 2022 Sep; 53(5):504-508. PubMed ID: 35713614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
    Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
    Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.
    Tajtakova M; Pidanicova A; Valansky L; Lachvac L; Nagy V; Sivonova M; Dobrota D; Kliment J; Petrovicova J
    Neoplasma; 2010; 57(2):118-22. PubMed ID: 20099974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.
    Rezamand G; Mahmoudi T; Tabaeian SP; Farahani H; Shahinmehr F; Nobakht H; Dabiri R; Asadi A; Mansour-Ghanaei F; Zali MR
    Physiol Int; 2021 Sep; 108(3):342-352. PubMed ID: 34529585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.
    Tabaeian SP; Mahmoudi T; Sabzikarian M; Rezamand G; Dabiri R; Nobakht H; Asadi A; Farahani H; Mansour-Ghanaei F; Zali MR
    J Gastrointestin Liver Dis; 2021 Jun; 30(2):233-239. PubMed ID: 34174062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
    Dabiri R; Mahmoudi T; Sabzikarian M; Asadi A; Farahani H; Nobakht H; Maleki I; Mansour-Ghanaei F; Derakshshan F; Zali MR
    Acta Gastroenterol Belg; 2020; 83(2):271-276. PubMed ID: 32603046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk.
    Tang W; Chen S; Liu J; Liu C; Wang Y; Kang M
    J Cell Biochem; 2019 Apr; 120(4):5510-5518. PubMed ID: 30335898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian population?
    Karimi K; Mahmoudi T; Karimi N; Dolatmoradi H; Arkani M; Farahani H; Vahedi M; Parsimehr E; Dabiri R; Nobakht H; Asadi A; Zali MR
    Asian Pac J Cancer Prev; 2013; 14(9):5011-6. PubMed ID: 24175768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between IGF1 Gene 3'-UTR polymorphisms and cancer risk: A Meta-analysis.
    Xu GP; Chen WX; Xie WY; Wu LF
    Medicine (Baltimore); 2018 Dec; 97(51):e13829. PubMed ID: 30572549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility.
    Yao Y; Zhu H; Zhu L; Fang Z; Fan Y; Liu C; Tian Y; Chen Y; Tang W; Ren Z; Li J; Yang S; Chen Y; Zhao X; Shen C
    Atherosclerosis; 2020 Mar; 296():59-65. PubMed ID: 32065979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinlike Growth Factor-1 and Its Binding Protein-3 Polymorphisms Predict Circulating IGF-1 Level and Appendicular Skeletal Muscle Mass in Chinese Elderly.
    Yang CW; Li TC; Li CI; Liu CS; Lin CH; Lin WY; Lin CC
    J Am Med Dir Assoc; 2015 May; 16(5):365-70. PubMed ID: 25548030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant rs6214 within IGF-1 confers risk for ulcerative colitis in Chinese Han populations.
    Wang H; Wang J; Geng C; Wang C; Gu R; Zhu Z
    Funct Integr Genomics; 2022 Dec; 23(1):1. PubMed ID: 36520299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IGF1 polymorphism rs6214 with high myopia: A systematic review and meta-analysis.
    Zhang D; Zeng G; Hu J; McCormick K; Shi Y; Gong B
    Ophthalmic Genet; 2017; 38(5):434-439. PubMed ID: 28135889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in genes of growth hormone receptor (GHR) and insulin-like growth factor-1 (IGF1) and its association with both the IGF1 expression in liver and its level in blood in Polish Holstein-Friesian cattle.
    Maj A; Snochowski M; Siadkowska E; Rowinska B; Lisowski P; Robakowska-Hyzorek D; Oprzadek J; Grochowska R; Kochman K; Zwierzchowski L
    Neuro Endocrinol Lett; 2008 Dec; 29(6):981-9. PubMed ID: 19112400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women.
    Mahmoudi T; Majidzadeh-A K; Karimi K; Karimi N; Farahani H; Dabiri R; Nobakht H; Dolatmoradi H; Arkani M; Zali MR
    Tumour Biol; 2015 May; 36(5):3709-15. PubMed ID: 25557790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk.
    Feik E; Baierl A; Hieger B; Führlinger G; Pentz A; Stättner S; Weiss W; Pulgram T; Leeb G; Mach K; Micksche M; Gsur A
    Cancer Causes Control; 2010 Jan; 21(1):91-7. PubMed ID: 19784788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.